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The choice to breastfeed when taking an antidepressant poses a dilemma for some 
women, with previous studies suggesting that women taking antidepressants have lower rates 
of breastfeeding intention and initiation. 
Newly Expressed 
 
Antidepressant use is associated with a reduced likelihood of breastfeeding at 
discharge from hospital, but this association appears to be strongly influenced by factors such 
as underlying maternal psychiatric illness and perinatal outcomes including preterm birth and 
neonatal hospital admission. 
Abstract 
Background: Few studies have investigated breastfeeding outcomes among women 
exposed to antidepressants.  
Research Aim: To evaluate the association between antidepressant use in late 
gestation and maternal psychiatric illness on breastfeeding rates at discharge from hospital.  
Methods: Retrospective cohort study of 32,662 women delivering live-born 
singletons between January 2001 to December 2008. Electronic hospital records were utilised 
to obtain data on antidepressant exposure during late gestation and whether mothers were 
breastfeeding at discharge from hospital following delivery.  
Results: Five hundred and seventy-five women received a dispensing for an 
antidepressant in late gestation (exposed), 1,552 did not receive a dispensing for an 
antidepressant but had a reported psychiatric illness (disease comparison) and 30,535 served 
as non-exposed controls. Exposed women were significantly less likely to be breastfeeding 
their infants at discharge from hospital compared to non-exposed women (adjusted odds ratio 
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[aOR] 0.63; 95%CI 0.50-0.80), but no statistically significant difference was observed when 
compared to women in the disease comparison group (aOR 0.83; 95%CI 0.65-1.07). In 
stratified analyses, compared to women in the disease comparison group, exposed women 
were significantly less likely to be breastfeeding their infants at discharge from hospital if 
their neonate was delivered at term (aOR 0.73; 95%CI 0.55-0.98), but not preterm (aOR 1.24; 
95%CI 0.66-2.32).  
Conclusion: While the negative association between antidepressant use and 
breastfeeding rates is confounded underlying maternal psychiatric illness, the association 
appears to differ according to neonatal outcome status. Overall, these results highlight that 




The benefits of breastfeeding are well established (Gartner et al., 2005; Hoddinott, 
Tappin, & Wright, 2008). A mother’s choice to breastfeed and her success in doing so, are 
influenced by a range of personal, social, and environmental factors. Maternal medication use 
has been highlighted as a potential barrier to breastfeeding due to concern regarding infant 
“exposure” through breast milk (Pearlstein et al., 2006). 
It is well recognised that antenatal depression and related psychiatric illnesses are 
significant risk factors for a range of adverse pregnancy outcomes (Bonaria et al., 2004; 
Ryan, Milis, & Misri, 2005). Included in this is a significant increased risk of major 
postpartum depressive illness, which affects up to 26.3% of women following delivery 
(Norhayati, Hazlina, Asrenee, Emilin, 2015). Maternal suicide has been reported as the 
leading cause of mortality in the first 12 months after birth in many countries (Cantwell et al., 
2011) and there are case reports of infanticide in the context of maternal psychiatric illness 
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(“Bringing postnatal depression out of the shadows”, 2012). Post-partum depression and 
related psychiatric illnesses are increasingly recognised as causing substantial morbidity and 
functional impairment in the mother and long-term negative consequences for infant and 
child development (Kendall-Tackett, & Hale, 2010; Quevedo et al., 2012; Stein et al., 2014). 
The growing body of evidence on the adverse effects associated with psychiatric illnesses in 
the perinatal period underscores the importance of appropriate and timely treatment.  
Antidepressants, particularly Selective Serotonin Reuptake Inhibitors (SSRIs) are 
commonly prescribed for many lactating women suffering from depression or related 
psychiatric illnesses (Howard et al., 2014). Despite this, few studies have investigated 
breastfeeding outcomes among women taking antidepressants. While the risks to the 
breastfed infant are considered low, the choice to breastfeed when taking an antidepressant 
may pose a dilemma for some women (Gorman, Kao, & Chambers, 2012). Anecdotal reports 
of concerns regarding infant “exposure” through breast milk may result in women taking 
antidepressants being less likely to breastfeed their infants. This is supported by two recent 
studies that demonstrated that women taking antidepressants have lower rates of 
breastfeeding intention and initiation (Bogen, Hanusa, Moses-Kolko, & Wisner, 2010; 
Gorman et al., 2012), but it is unclear what role underlying maternal illness may play. 
Given serotonin plays a role as a regulator of lactation homeostasis, medications such 
as antidepressants, that inhibit serotonin reuptake may also disrupt the normal physiological 
process associated with lactation. In line with this, one study has previously demonstrated 
that primiparous women taking SSRIs are at a 2-fold increased risk of delayed stage II 
lactogenesis (Marshall et al., 2010). 
Therefore, given the paucity of existing evidence, this study aimed to evaluate the 
association between antidepressant use in late-gestation and maternal psychiatric illness on 
breastfeeding rates at discharge from hospital. 




This study was approved by the Women’s and Children’s Health Network (WCHN) 
Human Research Ethics Committee.  
Study Design and Setting 
Retrospective cohort study relating to all live births in the Women’s and Children’s 
Health Network (WCHN) between January 2001 and December 2008. The study used 
linkable health administrative data that included the Women’s and Children’s Hospital 
(WCH) Perinatal Statistics Collection (PSC) and the WCH Pharmacy Dispensing Records. 
The WCH is a specialist metropolitan tertiary level teaching hospital and South Australia’s 
largest maternity and obstetric service, providing care for over 4000 pregnancies each year. 
Study Sample 
During the study period there were a total of 34,954 births. Women who were eligible 
for inclusion in the analysis were those who gave birth to a singleton, live born infant (n = 
32,662). 
Measures 
Antidepressant use and psychiatric illness.  
Data on exposure to antidepressants during pregnancy were obtained from the WCH 
Pharmacy Dispensing Records. Women were classified as exposed if they were dispensed an 
antidepressant during late-gestation (second and third trimesters). The hospital pharmacy 
dispensing records have previously been validated as an indicator of exposure to 
antidepressants in late pregnancy, including exposure around the time of delivery 
(Grzeskowiak, Gilbert, & Morrison, 2010). In an effort to obtain a suitable comparison group 
consisting of women with similar underlying disease as those exposed to antidepressants 
during pregnancy, we identified a cohort of women with an identified psychiatric illness 
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during pregnancy but who were not dispensed an antidepressant (disease comparison). The 
remaining group consisted of women who did not have a psychiatric illness and were not 
dispensed an antidepressant (non-exposed).  
Breastfeeding status.  
The primary outcome measure was breastfeeding status at discharge from hospital, 
which is routinely assessed and recorded on discharge for all women who deliver in the 
hospital. These data are collected and stored within the electronic WCH PSC.  
Covariates.  
The WCH PSC contains data on every live birth and late fetal death occurring at the 
WCH. Data are collected from each woman’s medical records after delivery by a specially 
trained research midwife. This is undertaken using a structured coding sheet. A more detailed 
description of the electronic data collected can be found elsewhere (Grzeskowiak, Gilbert, & 
Morrison, 2012). In addition to data on breastfeeding outcomes, the PSC was used to obtain 
data on a range of potential confounders including maternal age, parity, smoking status, race, 
socioeconomic status, history of substance abuse, year of delivery, use of other psychotropic 
medications, and the presence of maternal psychiatric illness. Women were defined as 
multiparous if they had ≥ 2 deliveries, including the pregnancy in question. Socioeconomic 
status for each woman was determined using her residential postcode at the time of delivery, 
as described in previous studies (Grzeskowiak et al., 2012). Data regarding antiepileptic, 
antipsychotic and anxiolytic use were also included. Preterm birth was defined as < 37 weeks 
gestation.  Of note, all supplementary birth records are checked manually for completeness 
and data discrepancies and then go through a series of automated validation procedures 
during data entry. The information in the PSC has been previously validated and has been 
shown to be reliable when compared with hospital case records (Pregnancy Outcome Unit, 
2001).  
Author’s Post-Print Version; Copyright – J Hum Lact; doi: 10.1177/0890334416678209 
 
Data Analyses 
Differences between groups in relation to breastfeeding status at discharge from 
hospital were compared using a χ2 test in addition to logistic regression models, generating 
odds ratios (ORs) and 95% confidence intervals (CIs). Adjustments were undertaken for the 
following potential confounders including maternal age, parity, smoking status, race, 
socioeconomic status, history of substance abuse, year of delivery and use of other 
psychotropic medications. Due to potential impact of preterm birth and neonatal hospital 
admission on breastfeeding at maternal discharge from hospital, additional analyses were 
undertaken following stratification of the cohort according to these variables. Statistical 
significance was defined as a 2-sided p <0.05. All statistical analyses were undertaken using 
STATA 11 (Stata, College Station, Texas). 
Results 
Among the total eligible cohort (n = 32,662), 575 (1.8%) women were dispensed an 
antidepressant in late gestation (exposed), 1,552 (4.8%) had a reported psychiatric illness 
during pregnancy but were not dispensed an antidepressant (disease comparison), and 30,535 
(93.5%) had no reported psychiatric illness during pregnancy and were not dispensed an 
antidepressant (non-exposed). 
Selective Serotonin Reuptake Inhibitors (SSRIs) were the most commonly dispensed 
class of medications (n=431; 75%), with all women identified as using monotherapy. Types 
of antidepressants included; sertraline [n=200], citalopram [n=139], venlafaxine [n=68], 
paroxetine [n=53], amitriptyline [n=30], fluoxetine [n=21], fluvoxamine [n=18] and 
mirtazapine [n=12]. 
Compared with women in the disease comparison group, exposed women were more 
likely to be older, of higher parity, non-smokers, be dispensed an antipsychotic or anxiolytic 
and deliver by caesarean section (Table 1). Compared with non-exposed women, exposed 
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women were more likely to be older, of higher parity, smokers, Caucasian, substance users, 
be dispensed an antiepileptic, antipsychotic or anxiolytic and deliver by caesarean section. 
Preterm birth (< 37 weeks) and neonatal admission to hospital occurred more frequently in 
exposed women in comparison with women both in the disease comparison group and those 
who were non-exposed. 
Women exposed to an antidepressant were significantly less likely to be breastfeeding 
their infants at discharge from hospital compared with non-exposed women (Table 2), but no 
statistically significant difference was observed when compared with women in the disease 
comparison group (Table 3). Women in the disease comparison group were also significantly 
less likely to be breastfeeding at discharge compared with non-exposed women (Table 3).  
In stratified analyses, compared to women in the disease comparison group, women 
exposed to antidepressants were significantly less likely to be breastfeeding their infants at 
discharge from hospital if their neonate was not admitted to the neonatal unit or was 
delivered at term (adjusted OR 0.73; 95% CI 0.55-0.98) (Table 3). In contrast, no 
associations were observed between antidepressant use and breastfeeding among the strata 
whose neonates were admitted to the neonatal unit or who delivered preterm.  
When examined according to type of antidepressant used, the proportion of women 
breastfeeding at discharge from hospital varied from 66% for paroxetine to 94% for 
fluvoxamine, but individual differences between antidepressants were not statistically 
significant (P=0.075; individual data not shown). Further sub-group analyses among women 
with a psychiatric illness identified a significant linear reduction in breastfeeding rates 
according to the number of psychotropic medications (e.g. anti-epileptics, benzodiazepines, 
antidepressants, antipsychotics) women were taking. For women taking 0, 1, 2, or 3 
psychotropics in total, the corresponding breastfeeding rates were 82%, 79%, 66%, and 47% 
respectively (ptrend <0.001). Among women exposed to antidepressants in late gestation, 
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women also taking antipsychotics had significantly lower rates of breastfeeding at discharge 
(46%) compared with women also taking anxiolytics (72%) or antiepileptics (87%). 
Following the exclusion of women exposed to psychotropics other than antidepressants 
(N=583), when compared to non-exposed women, a similar association between 
antidepressant use (adjusted OR 0.60; 95% CI 0.47-0.77) and reduced breastfeeding at 
discharge from hospital was observed. 
Discussion 
When examining the association between antidepressant use and breastfeeding 
outcomes, these findings are consistent with those by Gorman et al. (2012) who reported 
antidepressant use at any stage during pregnancy was significantly associated with reduced 
rates of breastfeeding initiation, however Gorman et al. (2012) did not account for underlying 
maternal illness. In contrast, while the findings of Bogen et al. (2010) demonstrated 
antidepressant use in pregnancy was negatively associated with breastfeeding intention, and 
continued antidepressant use following delivery was negatively associated with 12-week 
breastfeeding status, the presence of depressive symptoms in pregnancy was not associated 
with breastfeeding intention, initiation or duration. The findings by Bogen et al. (2010) would 
suggest antidepressant use, rather than underlying maternal illness, is the key factor 
influencing breastfeeding outcomes. 
When stratified according to mothers whose infants were not admitted to hospital or 
were born at term, the significant association between antidepressant use and reduced 
likelihood of breastfeeding at discharge from hospital among exposed mothers compared to 
the disease control group was unexpected. Given maternal antidepressant use is a well noted 
risk factor for preterm birth and neonatal withdrawal symptoms, both of which often lead to 
admission to the neonatal unit (Grzeskowiak, Gilbert, & Morrison, 2011), one could expect 
that these mothers may be less likely to breastfeed their infants through possible guilt of 
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exposing them to antidepressants during pregnancy. One could hypothesise that the lack of an 
association among the group whose infants were admitted to hospital or were preterm could 
relate to the increased breastfeeding supports provided to these mothers in the neonatal unit. 
It is possible that such supports may have been able to overcome whatever challenges 
antidepressants use or underlying maternal illness may pose. These mothers may also have 
been encouraged to breastfeed in an effort to reduce the incidence or severity of potential 
neonatal withdrawal from the antidepressant or other psychotropic medications. In contrast, 
the group of mothers whose infants did not require additional neonatal care may not have 
received such additional support or attention. 
Antidepressants aside, the presence of maternal psychiatric illness such as depression 
has been previously demonstrated itself to be associated with a reduction in breastfeeding 
intention, initiation, and duration (Bascom & Napolitano, 2016; Hatton et al., 2005). A recent 
study explored specific reasons for breastfeeding discontinuation among women with 
postnatal depression and observed that the main factors related to maternal lactation issues 
rather than psychosocial or convenience issues (Bascom & Napolitano, 2016). While 
lactation issues, such as perceived low milk supply, can often be addressed through 
appropriate lactation support, it has been demonstrated that maternal illness can negatively 
impact milk supply. Links between maternal stress and impaired lactogenesis have been 
observed in human and animal models (Dewey, 2001). Such an underlying physiological 
effect may therefore not be so easily modifiable without addressing the underlying cause and 
ensuring women are receiving appropriate treatment for their psychiatric illness. 
This leads to a focus on a common treatment for a range of psychiatric illnesses, 
antidepressants. Despite increasing evidence supporting the safety of antidepressants in 
lactation, maternal and clinician safety concerns may be a factor associated with reduced 
breastfeeding rates. Data largely demonstrate small amounts of antidepressants are 
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transferred into breast milk with infant plasma levels reported as undetectable or not of 
clinical significance (Kendall-Tackett & Hale, 2010). In general, misinformation surrounding 
the use of antidepressants in breastfeeding is a likely contributor to safety concerns regarding 
their use in this population. It is well recognised patients use Internet based resources to 
obtain health information, however many of these may be of poor quality and are often 
unreferenced or based on limited scientific evidence (Fioretti, Reiter, Betrán, & Torloni, 
2015). Health professionals have a responsibility to equip women with the critical questions 
to assess the quality of information they are viewing and direct them to reputable internet 
sources (Jesper, 2015). Manufacturer’s Consumer Medicines Information (CMI) is a 
misleading source of information for women (Amir, 2007); the statements are often cautious 
and in our experience negatively perceived by women. Studies have shown health 
professionals possess varying knowledge on the safety of medications in breastfeeding and 
frequently obtain information through manufacturer Product Information (de Ponti, Stewart, 
Amir, & Hussainy, 2015; Jayawickrama, Amir, & Pirotta, 2010). While the Product 
Information is readily accessible through prescribing software, information is often outdated 
and rarely advises a medication is safe in breastfeeding despite supporting studies. It is 
important the dissemination of correct information extends beyond breastfeeding women. 
Clinicians need to be aware of resources that are readily available to address the safety of 
medications in lactation, including the National Library of Medicines Drugs and Lactation 
Database (LactMed; http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm), textbooks (Hale & 
Rowe, 2014) and locally based Teratology or Medicines Information Services (Grzeskowiak, 
2015). Increased awareness of these resources would assist clinicians and patients to make 
better informed decisions around medication use in breastfeeding. 
Concern regarding maternal psychiatric illness may also influence breastfeeding rates. 
Poor sleep quality has been shown to worsen symptoms of psychiatric illness and as such 
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women may be advised against breastfeeding in order to reduce adverse impacts on mental 
health. We also noted multiple maternal psychotropic medication use was negatively 
associated with breastfeeding rates. This may be reflective of the severity of maternal illness 
and anxiety regarding the safety of polypharmacy in lactation. 
A strength of this study is the comparison between breastfeeding initiation rates in 
women taking antidepressants with women having a psychiatric illness but no antidepressant 
use. As such, we were able to explore breastfeeding rates, taking into account unmeasured 
factors associated with having a psychiatric illness that we were not able to adjust for in the 
multivariate analysis. In comparison, other studies did not adjust for underlying maternal 
disease. 
There are a number of limitations associated with this study. Firstly, no formal 
assessment for determinants of intention to breastfeed was undertaken, therefore it is possible 
some women did not intend to breastfeed irrespective of antidepressant use. Secondly, there 
was no measure of the type and severity of maternal psychiatric illness, which would have 
added to understanding the independent effects of psychiatric illness on breastfeeding 
outcomes. As such, there remains the potential for confounding due to underlying severity of 
psychiatric illness. Thirdly, the dose and indication of antidepressant use was not assessed. 
These factors may play an important role in decisions on breastfeeding. For example, women 
taking higher doses may be advised against breastfeeding by their clinician. Fourthly, this 
was a single site study at a large specialist public metropolitan tertiary level teaching hospital 
and thus it is not clear if these findings are generalisable to all women. Lastly, we were not 
able to determine if the women were still taking the medication while breastfeeding. It is 
possible they may have been taking it at the time of delivery but stopped soon after in order 
to breastfeed. Further research is warranted to determine what happens with antidepressant 
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use following delivery and during breastfeeding and the outcomes on maternal and 
infant/child health. 
Conclusion 
Antidepressant use is associated with a reduced likelihood of breastfeeding at 
discharge from hospital, but this association appears to be strongly influenced by factors such 
as underlying maternal psychiatric illness and perinatal outcomes including preterm birth and 
neonatal hospital admission. While the use of antidepressants did not appear to have an 
overall strong influence on breastfeeding outcomes independent of underlying maternal 
psychiatric illness, other aspects worthy of future research include the impact of information 
sources on clinician and patient decisions regarding medication safety in lactation, as well as 
longer-term breastfeeding outcomes in women using antidepressants in lactation. 
Identification of these factors would further assist in elucidating the most appropriate way to 
educate and support women with a psychiatric illness in order to improve breastfeeding rates. 
It is likely an individual approach with tailored recommendations will provide the greatest 
benefit to these patients. Overall, women taking antidepressants and women with a 
psychiatric illness may benefit from additional education and support to improve 
breastfeeding rates. 
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Table 1. Demographic and Clinical Measures for Women Exposed to 



















Age (years)    
     ≤19 27 (4.7) 125 (8.1) 1 526 (5.0) 
     20-34 423 (73.6) 1 148 (74.0) 23 347 (76.5) 
     ≥35 125 (21.7) 279 (18.0) 5 662 (18.5) 
Parity≥1  375 (65.7)  877 (56.8) 16 869 (55.5) 
Smoking Status    
     Non-Smoker 359 (63.8) 856 (55.6.0) 23 351 (78.8) 
     Quit During Pregnancy 20 (3.6) 98 (6.4) 1 184 (4.0) 
     Smoker 184 (32.7) 574 (37.6) 5 115 (17.3) 
Socioeconomic Status, 
SEIFA 
   
     5 (Highest) 113 (19.7) 276 (17.8) 5 947 (19.5) 
     4 107 (18.6) 283 (18.3) 6 127 (20.1) 
     3 99 (17.3) 311 (20.1) 5 618 (18.5) 
     2 106 (18.5) 281 (18.1) 6 111 (20.1) 
     1 (Lowest) 149 (26.0) 399 (25.7) 6 650 (21.8) 




















Race    
     Caucasian 526 (91.5) 1 361 (87.7) 23 953 (78.4) 
     Asian 13 (2.3) 55 (3.5) 3 601 (11.8) 
     Other 36 (6.3) 136 (8.8) 2 981 (9.8) 
Substance Abuse 50 (8.7) 174 (11.2) 747 (2.5) 
Psychotropic Medication 
Use 
   
     Antiepileptic 15 (2.6) 33 (2.1) 211 (0.7) 
     Antipsychotic 36 (6.3) 47 (3.0) 0 
     Anxiolytic 54 (9.4) 225 (14.5) 0 
Delivery Type    
     Caesarean Section 211 (36.7) 463 (29.8) 8 408 (27.5) 
     Normal Vaginal Delivery 364 (63.3) 1 089 (70.2) 22 127 (72.5) 
Neonate Admitted to 
Hospital 
236 (41.0) 404 (26.0) 5 756 (18.9) 
Preterm Birth 121 (21.0) 179 (11.5) 3 233 (10.6) 
Abbreviations: SEIFA, Socio-Economic Indexes for Areas 
† Percentages are calculated from non-missing data 
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Table 2. Number of Women Breastfeeding at Discharge from Hospital According to Maternal Exposure to Antidepressants, Psychiatric 
Illness Without Antidepressants, or Neither During Pregnancy 






















Entire Cohort (N=32,662) 575 445 77.4 
(73.8-80.6) 
1,552 1,253 80.7 
(78.7-82.6) 
30,535 27,130 88.9 
(88.5-89.2) 
<0.001 
Neonate Admitted to NNU   
Yes 
(n=6,396) 
236 175 74.2 
 (68.2-79.3) 
404 272 67.8 
(63.1-72.2) 





339 270 79.6  
(75.0-83,6) 
1,148 979 85.3 
(83.1-87.2) 
24,779 22,318 90.1 
(89.7-90.4) 
<0.001 
Preterm Birth   
Yes 
(n=3,533) 
121 94 77.7 
(69.4-84.3) 
179 131 73.2 
(66.2-79.2) 
3,233 2,715 84.0 
(82.7-85.2) 
<0.001 






454 351 77.3 
(73.3-80.9) 
1,373 1,122 81.7 
(79.6-83.7) 
27,302 24,414 89.4 
(89.1-89.8) 
<0.001 
Abbreviations: CI, confidence interval 
†  p-value calculated from χ2 test  
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Table 3. Univariate and Multivariate Logistic Regression Models of Breastfeeding Rates at Discharge from 
Hospital According to  Maternal Exposure to Antidepressants, Psychiatric Illness Without Antidepressants, or 
Neither During Pregnancy 
 Antidepressant Use  
Vs.  Control 
Antidepressant Use  






Vs.  Control 




















0.83 (0.65-1.07) 0.53 (0.46-
0.60) 
0.75 (0.64-0.88) 
Neonate Admitted to 
NNU 
      






1.28 (0.86-1.92) 0.41 (0.33-
0.52) 
0.65 (0.49-0.86) 










0.70 (0.50-0.97) 0.64 (0.54-
0.76) 
0.82 (0.68-0.99) 
Preterm Birth       






1.24 (0.66-2.32) 0.52 (0.37-
0.73) 
0.83 (0.54-1.30) 






0.73 (0.55-0.98) 0.53 (0.46-
0.61) 
0.74 (0.62-0.87) 
Abbreviations: OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval 
†  OR adjusted for maternal age, parity, smoking status, race, socioeconomic status, substance abuse, year of delivery, psychotropic 
medication use 
